针对可扩展治疗生产的二介质配方的表征和设计
Jinsung Song1, Seo-Young Park1, Dong-Yup Lee2
1School of Chemical Engineering, Sungkyunkwan University, 2066 Seobu-Ro, Jangan-GuGyeonggi-Do 16419, Suwon-Si, South Korea.
Applied microbiology and biotechnology
|January 14, 2025
概括
二胺为生物制药制造中的氨基酸不稳定提供了解决方案,改善了细胞培养性能. 定制的二聚策略,整合多组学和人工智能,可以提高生物工艺的效率.
科学领域:
- 生物制药制造业 生物制药制造业
- 细胞培养技术 细胞培养技术
- 生物工艺工程 生物工艺工程
背景情况:
- 传统的介质设计在大型生物制药生产中面临氨基酸稳定性和溶解性的挑战.
- 氨基酸如谷氨胺,氨酸和氨酸呈现特定的不稳定性和可溶性问题.
- 滴体正在成为可行的替代品,以克服这些局限性,在中国仓鼠卵巢 (CHO) 细胞制造中.
研究的目的:
- 批判性地分析生物制造中常规氨基酸的局限性.
- 探索 dipeptides 的潜力,作为提高细胞培养性能和过程一致性的策略.
- 为合理的二设计提出综合方法,以适应生物制造的需求.
主要方法:
- 在细胞培养中对氨基酸和二的利用现有文献的审查.
- 对二化物运输机制和酶分裂通路的分析.
- 整合多组学,代谢流量建模和人工智能 (AI) 来开发二战略.
主要成果:
- 与某些氨基酸相比,二酸显示出更好的溶解性.
- 双的利用受化学性质,立体异构和竞争性代谢物的影响.
- 稳定效应和培养性能的变化需要合理的设计方法.
结论:
- 滴是解决生物制药制造中的氨基酸不稳定性和可溶性问题的有希望的策略.
- 了解二聚的运输和裂变对于优化它们的使用至关重要.
- 通过先进的建模,量身定制的二聚策略可以显著提高生物过程的效率和一致性.
更多相关视频
13:34Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
11.5K
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.0K
相关概念视频
Designing Growth Media for Bioreactors
67
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
67
Scale-Up Processes
89
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
89
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87
Production of Antibiotics
162
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
162
Production of Pharmaceuticals
70
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
70
